Packages (Simulation)
Reagent Preparation
Image (I)
-
Results demonstration
Image (II)
-
Typical Standard Curve
Quality Guarantee
Instruction Manual
Certificate
Maybe you can also pay attention to our smart microplate reader
Wide-range ELISA Kit for Complement Factor I (CFI)
CF-I; C3b-INA; FI; IF; KAF; Factor I; Konglutinogen-Activating Factor; C3b-Inactivator; C3B/C4B inactivator
- Product No.WEB978Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample Typeserum, plasma and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Range6.25-400ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 2.85ng/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 442
US$ 632
US$ 2844
US$ 5372
US$ 44240
For more details, please contact local distributors!
Specificity
This assay has high sensitivity and excellent specificity for detection of Wide-range Complement Factor I (CFI).
No significant cross-reactivity or interference between Wide-range Complement Factor I (CFI) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Wide-range Complement Factor I (CFI) and the recovery rates were calculated by comparing the measured value to the expected amount of Wide-range Complement Factor I (CFI) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 80-102 | 81 |
| EDTA plasma(n=5) | 98-105 | 102 |
| heparin plasma(n=5) | 96-105 | 101 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Wide-range Complement Factor I (CFI) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Wide-range Complement Factor I (CFI) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Wide-range Complement Factor I (CFI) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 86-102% | 95-104% | 94-101% | 86-101% |
| EDTA plasma(n=5) | 91-101% | 96-104% | 78-91% | 80-97% |
| heparin plasma(n=5) | 91-99% | 95-104% | 80-92% | 84-98% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
| Standard | 2 | Standard Diluent | 1×20mL |
| Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
| Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
| TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
| Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations |
| J Thromb Haemost | A case report of thrombotic microangiopathy without renal involvement carrying two novel mutations in complement-regulator genes PubMed: 26613809 |
| Pediatr Int | Atypical hemolytic uremic syndrome: Korean pediatric series PubMed: 25443527 |
| United States Patent Application | NOVEL ASSAY y2016:139118 |
| Researchgate | Compliment factor i bioassay US20170285024 |
| PLoS One | A monoclonal antibody targeting amyloid β (Aβ) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and … Pubmed:29782502 |
| JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | The importance of sialic acid, pH and ion concentration on the interaction of uromodulin and complement factor H 33788378 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPB978Hu02 | Recombinant Complement Factor I (CFI) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB978Hu01 | Recombinant Complement Factor I (CFI) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB978Hu01 | Polyclonal Antibody to Complement Factor I (CFI) | WB; IHC; ICC; IP. |
| PAB978Hu02 | Polyclonal Antibody to Complement Factor I (CFI) | WB; IHC; ICC; IP. |
| MAB978Hu22 | Monoclonal Antibody to Complement Factor I (CFI) | WB; IHC; ICC; IP. |
| WEB978Hu | Wide-range ELISA Kit for Complement Factor I (CFI) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEB978Hu | ELISA Kit for Complement Factor I (CFI) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB978Hu | Multiplex Assay Kit for Complement Factor I (CFI) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |